Cargando…

Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment

Neurofibromatosis type 1 (NF1) is an autosomal-dominant neurogenetic disorder caused by mutations in the gene neurofibromin 1 (NF1). NF1 predisposes individuals to a variety of symptoms, including peripheral nerve tumors, brain tumors and cognitive dysfunction. Cognitive deficits can negatively impa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Andrew H., Halloran, Mary C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Ltd 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459395/ https://www.ncbi.nlm.nih.gov/pubmed/36037004 http://dx.doi.org/10.1242/dmm.049422

Ejemplares similares

Spontaneous and Engineered Large Animal Models of Neurofibromatosis Type 1
por: Osum, Sara H., et al.
Publicado: (2021)

Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights
por: Du, Jiajia, et al.
Publicado: (2021)

Cognitive and Electrophysiological Correlates of Working Memory Impairments in Neurofibromatosis Type 1
por: Pobric, Gorana, et al.
Publicado: (2021)

Does Cognitive Impairment Explain Behavioral and Social Problems of Children with Neurofibromatosis Type 1?
por: Huijbregts, Stephan C. J., et al.
Publicado: (2010)

Animal Models of Preeclampsia: Mechanistic Insights and Promising Therapeutics
por: Taylor, Erin B, et al.
Publicado: (2022)

Cerebellum-dependent associative learning is not impaired in a mouse model of neurofibromatosis type 1
por: Ottenhoff, M. J., et al.
Publicado: (2022)

NFB-15. "Cognitive Impairments in Children and Adolescents with Neurofibromatosis"
por: Mavrea, Kalliopi, et al.
Publicado: (2022)

Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1
por: Torres Nupan, Martha Milade, et al.
Publicado: (2017)

Zebrafish model of neurofibromatosis type 1
Publicado: (2012)

Neurofibromatosis Type-2 presenting with vision impairment
por: Alshoabi, Sultan Abdulwadoud
Publicado: (2023)

Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1
por: Payne, Jonathan M., et al.
Publicado: (2019)

Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
por: Santoro, Claudia, et al.
Publicado: (2018)

Neurofibromatosis type 1
por: Mançano, Alexandre Dias
Publicado: (2022)

The efficacy of statins for improving cognitive impairments in pediatric patients with neurofibromatosis type 1 (NF-1): a meta-analysis
por: Gan, Lutong, et al.
Publicado: (2023)

Increased risk of breast cancer in neurofibromatosis type 1: current insights
por: Howell, Sacha J, et al.
Publicado: (2017)

Insights into Novel Choroidal and Retinal Clinical Signs in Neurofibromatosis Type 1
por: Mallone, Fabiana, et al.
Publicado: (2023)

Models and Mechanistic Insight
por: Pugh, Edward N., et al.
Publicado: (2008)

Animal models of congenital zika syndrome provide mechanistic insight into viral pathogenesis during pregnancy
por: Narasimhan, Harish, et al.
Publicado: (2020)

Plexiform neurofibromatosis type 1
por: Sharma, Surendra K., et al.
Publicado: (2016)

Neurofibromatosis Type 1 in the Mandible
por: Uchiyama, Yuka, et al.
Publicado: (2018)

Hemostasis and Type 1 Neurofibromatosis
por: Niddam, Jeremy, et al.
Publicado: (2017)

Impairment of Procedural Learning and Motor Intracortical Inhibition in Neurofibromatosis Type 1 Patients
por: Zimerman, Máximo, et al.
Publicado: (2015)

Brain tumors in neurofibromatosis type 1
por: Costa, Amanda De Andrade, et al.
Publicado: (2019)

Cranio-orbital-temporal neurofibromatosis: An uncommon subtype of neurofibromatosis type-1
por: Acharya, Nibedita, et al.
Publicado: (2014)

Mild cognitive impairment: animal models
por: Pepeu, Giancarlo
Publicado: (2004)

Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1
por: Mainberger, Florian, et al.
Publicado: (2013)

Predictive Modeling for Clinical Features Associated With Neurofibromatosis Type 1
por: Morris, Stephanie M., et al.
Publicado: (2021)

Bridging the Gap Between Mouse Behavior and Human Cognition in Neurofibromatosis Type 1
por: Payne, Jonathan M.
Publicado: (2015)

Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1
por: Ottenhoff, Myrthe J., et al.
Publicado: (2020)

Neurofibroma Development in Neurofibromatosis Type 1: Insights from Cellular Origin and Schwann Cell Lineage Development
por: Ge, Ling-Ling, et al.
Publicado: (2022)

Computational Psychiatry and Computational Neurology: Seeking for Mechanistic Modeling in Cognitive Impairment and Dementia
por: Kucikova, Ludmila, et al.
Publicado: (2022)

Statins, bone, and neurofibromatosis type 1
por: Korf, Bruce R
Publicado: (2008)

Moyamoya syndrome and neurofibromatosis type 1
por: Vargiami, Euthymia, et al.
Publicado: (2014)

Neurofibromatosis Type 1 with Bladder Involvement
por: Üre, Iyimser, et al.
Publicado: (2013)

Becker's nevus with neurofibromatosis type 1
por: Kar, Sumit, et al.
Publicado: (2015)

Constipation in adults with neurofibromatosis type 1
por: Ejerskov, Cecilie, et al.
Publicado: (2017)

Cutaneous Findings in Neurofibromatosis Type 1
por: Ozarslan, Bengisu, et al.
Publicado: (2021)

Bone Manifestations of Neurofibromatosis Type 1
por: Diallo, Ibrahima Dokal, et al.
Publicado: (2022)

Endocrinological Evaluations of a Neurofibromatosis Type 1 Cohort: Is it Necessary to Evaluate Autoimmune Thyroiditis in Neurofibromatosis Type 1?
por: Güler, Serhat, et al.
Publicado: (2017)

Mechanistic Insight into Orthodontic Tooth Movement Based on Animal Studies: A Critical Review
por: Jeon, Hyeran Helen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7lvcmet4lnbdskuc1ldufbcvv1